Call Options

20 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.43 - $70.83 $14.1 Million - $23.5 Million
332,200 New
332,200 $22.6 Million
Q1 2022

May 17, 2022

BUY
$57.56 - $82.54 $2.23 Million - $3.19 Million
38,700 Added 37.32%
142,400 $9.96 Million
Q4 2021

Feb 15, 2022

SELL
$72.5 - $100.68 $804,750 - $1.12 Million
-11,100 Reduced 9.67%
103,700 $8.07 Million
Q3 2021

Nov 16, 2021

SELL
$90.24 - $124.05 $1.68 Million - $2.31 Million
-18,600 Reduced 13.94%
114,800 $11 Million
Q2 2021

Aug 16, 2021

BUY
$93.66 - $139.27 $927,234 - $1.38 Million
9,900 Added 8.02%
133,400 $16.6 Million
Q1 2021

May 18, 2021

SELL
$116.57 - $155.01 $7.46 Million - $9.92 Million
-64,000 Reduced 34.13%
123,500 $16.3 Million
Q4 2020

Feb 17, 2021

BUY
$99.61 - $142.12 $846,685 - $1.21 Million
8,500 Added 4.75%
187,500 $24.8 Million
Q3 2020

Nov 17, 2020

SELL
$72.92 - $102.01 $4 Million - $5.6 Million
-54,900 Reduced 23.47%
179,000 $18.2 Million
Q2 2020

Aug 17, 2020

BUY
$55.75 - $92.75 $5.07 Million - $8.43 Million
90,900 Added 63.57%
233,900 $20.3 Million
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $2.41 Million - $6.64 Million
-63,600 Reduced 30.78%
143,000 $8.29 Million
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $10.8 Million - $13.9 Million
139,300 Added 206.98%
206,600 $19.1 Million
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $1.6 Million - $2.17 Million
17,700 Added 35.69%
67,300 $6.08 Million
Q2 2019

Aug 15, 2019

BUY
$89.51 - $118.04 $89,510 - $118,040
1,000 Added 2.06%
49,600 $5.86 Million
Q1 2019

May 16, 2019

SELL
$61.98 - $96.5 $10.6 Million - $16.4 Million
-170,300 Reduced 77.8%
48,600 $4.21 Million
Q4 2018

Feb 15, 2019

BUY
$56.04 - $82.66 $8.26 Million - $12.2 Million
147,400 Added 206.15%
218,900 $13.8 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $487,729 - $814,060
-10,100 Reduced 12.38%
71,500 $5.64 Million
Q2 2018

Aug 15, 2018

BUY
$37.84 - $69.96 $980,056 - $1.81 Million
25,900 Added 46.5%
81,600 $4.88 Million
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $111,496 - $161,084
-2,800 Reduced 4.79%
55,700 $2.25 Million
Q4 2017

Feb 15, 2018

SELL
$46.49 - $60.51 $529,986 - $689,814
-11,400 Reduced 16.31%
58,500 $3.07 Million
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $2.59 Million - $3.29 Million
69,900
69,900 $3.29 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.